Summary
UnitedHealth Group (UNH) reported its second-quarter 2021 financial results, demonstrating robust revenue growth driven by both its UnitedHealthcare and Optum segments. Total revenues increased by 15% year-over-year to $71.3 billion, with UnitedHealthcare revenues up 13% and Optum revenues growing 17%. This growth was supported by an increase in the number of individuals served across Medicare Advantage and Medicaid programs, alongside expansion in Optum's care delivery and managed services. Despite strong revenue performance, earnings from operations saw a notable decline of 35% year-over-year to $6.0 billion. This was primarily attributed to the reduction in temporary care deferrals related to the COVID-19 pandemic, which, while easing, still impacted the comparison against the prior year when deferrals were more significant. Additionally, increased COVID-19 related care costs and rebate requirements also weighed on profitability. Diluted earnings per share decreased to $4.46 from $6.91 in the prior year's second quarter. The company also announced an increase in its quarterly cash dividend and continues to pursue strategic acquisitions, including the notable pending acquisition of Change Healthcare.
Financial Highlights
55 data points| Revenue | $71.32B |
| Cost of Revenue | $7.66B |
| Gross Profit | $63.66B |
| SG&A Expenses | $10.36B |
| Operating Expenses | $65.34B |
| Operating Income | $5.98B |
| Interest Expense | $410.00M |
| Net Income | $4.27B |
| EPS (Basic) | $4.52 |
| EPS (Diluted) | $4.46 |
| Shares Outstanding (Basic) | 944.00M |
| Shares Outstanding (Diluted) | 956.00M |
Key Highlights
- 1Total revenues surged 15% to $71.3 billion for the second quarter of 2021, indicating strong top-line growth.
- 2UnitedHealthcare segment revenue increased by 13% year-over-year, driven by growth in Medicare Advantage and Medicaid enrollment.
- 3Optum segment revenue grew by 17%, demonstrating strong performance across its various business lines.
- 4Earnings from operations declined by 35% to $6.0 billion, largely due to the normalization of COVID-19 related care deferrals from the prior year's elevated levels.
- 5Diluted EPS decreased to $4.46 from $6.91 in the prior year's second quarter, reflecting the impact of lower earnings from operations.
- 6The company increased its quarterly cash dividend to an annual rate of $5.80 per share, signaling confidence in its financial stability and commitment to shareholder returns.
- 7UnitedHealth Group is pursuing a significant acquisition of Change Healthcare, subject to regulatory approvals, which could reshape its market position.